A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/445 (2006.01) A61K 31/35 (2006.01) A61K 31/40 (2006.01)
Patent
CA 2180178
Methods and pharmaceutical compositions for reducing bone loss are disclosed. 2,3-Diaryl-1- benzopyrans and their pharmaceutically acceptable salts are formulated into medicaments for the treat- ment of bone loss due to osteoperosis or other con- ditions. Formulations include tablets and other forms suitable for oral administration and controlled-release subdermal implants.
L'invention se rapporte à des procédés et à des compositions pharmaceutiques utilisés pour réduire la diminution du volume du tissu osseux. Les formulations des 2,3-diaryl-1-benzopyranes et leurs sels pharmaceutiquement acceptables permettent d'obtenir des médicaments utilisés dans le traitement de la diminution du volume du tissu osseux due à l'ostéoporose ou à d'autres états. Ces formulations sont des comprimés et autres formes galéniques appropriées à l'administration orale et aux implants sous-dermiques à libération contrôlée.
Ledgley Law
Zymogenetics Inc.
LandOfFree
Use of 2,3-diaryl-1-benzopyran derivatives for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 2,3-diaryl-1-benzopyran derivatives for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 2,3-diaryl-1-benzopyran derivatives for the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2002334